Women’s Heart
Initiative Program
WHIP is a Prevention Program Designed Specifically for Women
Heart disease is the leading cause of death in women.Yet most risk models, testing standards, and symptom descriptions were originally built around male data.
Women’s Heart
Initiative Program
WHIP is a Prevention Program Designed Specifically for Women
Heart disease is the leading cause of death in women.Yet most risk models, testing standards, and symptom descriptions were originally built around male data.
The Women’s Heart Initiative Program, WHIP, was created to change that.
This is a physician-led, prevention-focused cardiovascular program designed specifically around how heart disease develops, presents, and progresses in women.
It is built on three pillars:
-
Reveal
-
React
-
Reassess
Why Women Need a Different Approach to Heart Disease
Women often experience:
-
Subtle or atypical symptoms
-
Delayed diagnosis
-
“Normal” test results despite ongoing risk
-
Risk factors unique to female biology
Pregnancy history. Early menopause. Autoimmune disease. Chronic inflammation. Anxiety-related mislabeling. These are rarely integrated properly into traditional cardiovascular care.
WHIP was built to address those gaps directly.
Because WHIP is structured and physician-led, enrollment is limited to five women per month to ensure depth, accuracy, and individualized attention.
The 3 Rs Framework
Reveal
Most heart disease does not begin with a crisis. It develops silently over time.
The first phase of WHIP is focused on uncovering risk before symptoms escalate.
This includes:
-
Comprehensive history and physical examination with emphasis on women-specific symptoms and early warning signs
-
Detailed evaluation of traditional and female-specific cardiovascular risk factors
-
Advanced laboratory testing, including markers not routinely assessed in standard screenings
-
Cardiovascular imaging tailored to risk profile
-
Creation of a personalized cardiovascular risk score
The goal is clarity. Not guesswork.
React
Once risk is clearly defined, we create a female-specific action plan. This is not a generic checklist. It is a structured, physician-guided strategy tailored to your biology, risk level, and life stage.
Your plan may include:
-
Lifestyle modification strategies
-
Personalized nutrition and dietary counseling
-
Exercise programming appropriate for your cardiovascular profile
-
Smoking cessation support
-
Anxiety and depression management when relevant
-
Targeted supplements and integrative therapies when appropriate
-
Ongoing physician support and monitoring
Prevention requires consistency. We build structure around that consistency.
Reassess
Prevention is not a one-time event. It is a process.
The final pillar of WHIP focuses on monitoring progress and adjusting strategy when needed. This includes:
-
Regular reassessment of your personalized cardiovascular risk score
-
Ongoing evaluation of disease progression or stability
-
Data-driven plan modifications
-
Long-term cardiovascular tracking
Because the goal is not temporary improvement. It is sustained cardiovascular health.
Because WHIP is structured and physician-led, enrollment is limited to five women per month to ensure depth, accuracy, and individualized attention.
Who WHIP Is Designed For
This program is ideal for:
-
Women with family history of heart disease
-
Women with pregnancy complications or early menopause
-
Women with autoimmune or inflammatory conditions
-
Women with borderline or unclear risk
-
Women told their tests are "normal" but who still feel something is not right
-
Women who want a proactive prevention strategy rather than reactive treatment
A Different Standard of Cardiovascular Care for Women
WHIP is not a quick consult.
It is a structured prevention program.
It is built on decades of clinical experience and a deep understanding of how cardiovascular disease presents differently in women.
Prevention is most powerful before symptoms appear.
Enrollment is limited to five women each month to ensure individualized oversight and meaningful results.
About Dr. Arash Bereliani
Dr. Arash Bereliani is board-certified in Cardiovascular Disease and Internal Medicine. He serves as a Clinical Associate Professor of Medicine and Cardiology at the David Geffen School of Medicine at UCLA and is on staff at Cedars-Sinai Medical Center. He is also the Medical Director of The Beverly Hills Institute of Cardiology and Preventive Medicine.
He earned his medical degree from Finch University of Health Sciences, graduating first in his class and earning induction into the Alpha Omega Alpha Medical Honor Society. He completed his Internal Medicine residency and Cardiology fellowship at Ronald Reagan UCLA Medical Center.
With more than twenty-eight years in practice, Dr. Bereliani focuses on prevention, early detection, and highly individualized cardiovascular care.
Join the Free Newsletter
Women’s Heart Digest
Women’s heart health is different, yet much of what we know is based on male-centered research. The result is missed signals and delayed diagnoses. This biweekly email shares what gets overlooked, from young, active women to pregnancy, menopause, and every stage in between.